Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
The Oncologist|July 19, 2011
Factors associated with altered long-term well-being after prophylactic salpingo-oophorectomy among women at increased hereditary risk for breast and ovarian cancerCyril Touboul, Catherine Uzan, Jean Laurent Ichanté, et al.
Annals of Surgical Oncology|September 21, 2013
Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thoughtSylvie Bonvalot, Nils Ternès, Marco Fiore, et al.
Anticancer Research|March 14, 2007
Differential immunohistochemical and biological profile of squamous cell carcinoma of the breastJulien Grenier, Jean-Charles Soria, Marie-Christine Mathieu, et al.
The Journal of Investigative Dermatology|February 8, 2013
Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysisPeggy Sekula, Ariane Dunant, Maja Mockenhaupt, et al.
Journal of the American Academy of Dermatology|October 9, 2007
Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and IsraelSima Halevy, Pierre-Dominique Ghislain, Maja Mockenhaupt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 30, 2010
Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic diseaseCéline Bourgier, Wassim Khodari, Anne-Lise Vataire, et al.
The Lancet. Oncology|April 24, 2009
Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trialCécile Le Péchoux, Ariane Dunant, Suresh Senan, et al.
Radiation Oncology (London, England)|August 24, 2012
Higher toxicity with 42 Gy in 10 fractions as a total dose for 3D-conformal accelerated partial breast irradiation: results from a dose escalation phase II trialCeline Bourgier, Catalina Acevedo-Henao, Ariane Dunant, et al.
The American Journal of Pathology|January 13, 2011
ERCC1 and RRM1 in the international adjuvant lung trial by automated quantitative in situ analysisGerold Bepler, Ken André Olaussen, Anne-Lise Vataire, et al.
Radiation Oncology (London, England)|January 1, 2010
3D-conformal accelerated partial breast irradiation treatment planning: the value of surgical clips in the delineation of the lumpectomy cavityMaia Dzhugashvili, Elodie Tournay, Charlotte Pichenot, et al.
Pageof 6